Phase II study of the c-SRC inhibitor AZD0530 after four cycles of cytoreductive chemotherapy for patients with extensive stage small cell lung carcinoma.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2017
At a glance
- Drugs Saracatinib (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 18 Jun 2012 Actual end date Nov 2008 added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Sep 2008 Basic check conducted, last updated 9-09-2008.